Your SlideShare is downloading. ×
The Future of Dermatology Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Prescription Rate to Drive Revenues
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Introducing the official SlideShare app

Stunning, full-screen experience for iPhone and Android

Text the download link to your phone

Standard text messaging rates apply

The Future of Dermatology Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Prescription Rate to Drive Revenues

213
views

Published on

The Future of Dermatology Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Prescription Rate to Drive RevenuesSummaryGBI Research has released its research - 'The Future of Dermatology …

The Future of Dermatology Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Prescription Rate to Drive RevenuesSummaryGBI Research has released its research - 'The Future of Dermatology Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Prescription Rate to Drive Revenues'. The report provides in-depth analysis of unmet needs, drivers and barriers that impact the global dermatology therapeutics market. The report analyzes the markets for dermatology therapeutics in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns and sales are forecast until 2016 for the key geographies as well as select therapeutic segments. Further, the report provides competitive benchmarking for the leading companies and also analyzes the mergers, acquisitions and licensing agreements that shape the global markets. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.ScopeThe scope of this report includes: - Annualized market data for the dermatology therapeutics market from 2001 to 2009, forecast forward to 2016 - Analysis of the leading therapeutic segments. These include Acne, Psoriasis, Dermatitis, Rosacea and Skin diseases. - Analysis of the dermatology therapeutics market in the leading geographies of the world, which include the US, the UK, Germany, France, Italy, Spain, and Japan - Market characterization of the dermatology therapeutics market including market size, annual cost of therapy, and treatment usage patterns - Key drivers and barriers that have a significant impact on the market - Coverage of pipeline molecules in various phases of drug development - Competitive benchmarking of leading companies. The key companies studied in this report are F.Hoffmann-La Roche, GlaxoSmithKline, Leo Pharma, Sanofi-Aventis, Genentech, Novartis AG, Johnson & Johnson, Galderma Pharma SA, and Merck & Co, Inc. - Key M&A activities, licensing agreements, that have taken place between 2008 and 2009 in the global dermatology therapeutics marketReasons to buyThe report will enhance your decision making capability. It will allow you to - Align product portfolio to the markets with high growth potential - Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth - Reinforce R&D pipelines by identifying new target mechanisms which can produce first in class molecules with more efficiency and better safety - Develop key strategic initiatives by understanding key focus areas of leading companies - Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps

Published in: Economy & Finance, Business

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
213
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!The Future of Dermatology Therapeutics, Analysis and MarketForecasts to 2016 - Increasing Prescription Rate to Drive RevenuesPublished on March 2010 Report SummaryThe Future of Dermatology Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Prescription Rate to Drive RevenuesSummaryGBI Research has released its research - The Future of Dermatology Therapeutics, Analysis and Market Forecasts to 2016 -Increasing Prescription Rate to Drive Revenues. The report provides in-depth analysis of unmet needs, drivers and barriers thatimpact the global dermatology therapeutics market. The report analyzes the markets for dermatology therapeutics in the US, the topfive countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns and sales are forecast until2016 for the key geographies as well as select therapeutic segments. Further, the report provides competitive benchmarking for theleading companies and also analyzes the mergers, acquisitions and licensing agreements that shape the global markets. This reportis built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBIResearchs team of industry experts.ScopeThe scope of this report includes:- Annualized market data for the dermatology therapeutics market from 2001 to 2009, forecast forward to 2016- Analysis of the leading therapeutic segments. These include Acne, Psoriasis, Dermatitis, Rosacea and Skin diseases.- Analysis of the dermatology therapeutics market in the leading geographies of the world, which include the US, the UK, Germany,France, Italy, Spain, and Japan- Market characterization of the dermatology therapeutics market including market size, annual cost of therapy, and treatment usagepatterns- Key drivers and barriers that have a significant impact on the market- Coverage of pipeline molecules in various phases of drug development- Competitive benchmarking of leading companies. The key companies studied in this report are F.Hoffmann-La Roche,GlaxoSmithKline, Leo Pharma, Sanofi-Aventis, Genentech, Novartis AG, Johnson & Johnson, Galderma Pharma SA, and Merck &Co, Inc.- Key M&A activities, licensing agreements, that have taken place between 2008 and 2009 in the global dermatology therapeuticsmarketReasons to buyThe report will enhance your decision making capability. It will allow you to- Align product portfolio to the markets with high growth potential- Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic marketspoised for strong growth- Reinforce R&D pipelines by identifying new target mechanisms which can produce first in class molecules with more efficiency andbetter safety- Develop key strategic initiatives by understanding key focus areas of leading companiesThe Future of Dermatology Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Prescription Rate to Drive Revenues Page 1/11
  • 2. Find Industry reports, Company profilesReportLinker and Market Statistics- Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps Table of Content1 Table of Contents1 Table of Contents 31.1 List of Tables 71.2 List of Figures 102 Global Dermatology Therapeutics Market: Scope of Research 122.1 Introduction 122.2 GBI Research Report Guidance 123 Global Dermatology Therapeutics Market: Market Characterization 133.1 Market Forecasts 133.2 Usage Patterns 143.2.1 Diseased Population 143.2.2 Treatment Seeking Population 153.2.3 Diagnosis Population 163.2.4 Prescription Population 173.2.5 Therapy Usage Patterns 183.2.6 Geographical Distribution 194 Global Dermatology Therapeutics Market: US Market 204.1 Market Overview 204.2 Market Forecasts 204.3 Usage Patterns 214.3.1 Diseased Population 214.3.2 Treatment Seeking Population 224.3.3 Diagnosis Population 234.3.4 Prescription Population 244.3.5 Therapy Usage Patterns 255 Global Dermatology Therapeutics Market: European Market 275.1 Market Overview 275.2 Market Forecasts 275.3 Usage Patterns 285.3.1 Diseased Population 285.3.2 Treatment Seeking Population 295.3.3 Diagnosis Population 305.3.4 Prescription Population 315.3.5 Therapy Usage Patterns 326 Global Dermatology Therapeutics Market : Japan Market 346.1 Market Overview 346.2 Market Forecasts 346.3 Usage Patterns 356.3.1 Diseased Population 356.3.2 Treatment Seeking Population 366.3.3 Diagnosis Population 376.3.4 Prescription Population 386.3.5 Therapy Usage Patterns 397 Global Psoriasis Therapeutics Market 41The Future of Dermatology Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Prescription Rate to Drive Revenues Page 2/11
  • 3. Find Industry reports, Company profilesReportLinker and Market Statistics7.1 Market Overview 417.2 Market Forecasts 427.3 Average Cost of Therapy 437.4 Usage Patterns 447.4.1 Diseased Population 447.4.2 Treatment Seeking Population 457.4.3 Diagnosis Population 467.4.4 Prescription Population 477.4.5 Therapy Usage Patterns 487.5 Product Analysis 507.5.1 Enbrel (etanercept) 507.5.2 Humira (adalimumab) 507.5.3 Amevive (alefacept) 517.5.4 Remicade (infliximab) 517.5.5 Stelara (ustekinumab, CNTO1275) 517.5.6 Clobex (clobetasol propionate) 517.5.7 Tazorac (tazarotene, Avage) 517.5.8 Dovonex (calcipotriene) 527.5.9 Neoral (cyclosporine) 527.6 Drug Pipeline Analysis 527.6.1 Psoriasis Therapeutics Phase III Clinical Pipeline 537.6.2 Psoriasis Therapeutics Phase II Clinical Pipeline 548 Global Atopic Dermatitis Therapeutics Market 578.1 Market Overview 578.2 Market Forecasts 578.3 Average Cost of Therapy 598.4 Usage Patterns 608.4.1 Diseased Population 608.4.2 Treatment Seeking Population 618.4.3 Diagnosis Population 628.4.4 Prescription Population 638.4.5 Therapy Usage Patterns 648.5 Product Analysis 658.5.1 Protopic (Tacrolimus) 658.5.2 Elidel (Pimecrolimus) 668.5.3 MimyX 668.5.4 Atopiclair 668.5.5 Topical Corticosteroids 668.6 Drug Pipeline Analysis 669 Global Acne Therapeutics Market 719.1 Market Overview 719.2 Market Forecasts 719.3 Usage Patterns 739.3.1 Diseased Population 739.3.2 Treatment Seeking Population 749.3.3 Diagnosis Population 759.3.4 Prescription Population 769.3.5 Therapy Usage Patterns 779.4 Product Analysis 789.5 Drug Pipeline Analysis 78The Future of Dermatology Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Prescription Rate to Drive Revenues Page 3/11
  • 4. Find Industry reports, Company profilesReportLinker and Market Statistics10 Global Rosacea Disease Therapeutics Market 8410.1 Market Overview 8410.2 Market Forecasts 8410.3 Average Cost of Therapy 8510.4 Usage Patterns 8610.4.1 Diseased Population 8610.4.2 Treatment Seeking Population 8710.4.3 Diagnosis Population 8810.4.4 Prescription Population 8910.4.5 Therapy Usage Patterns 9010.5 Product Analysis 9110.6 Drug Pipeline Analysis 9211 Global Dermatology Therapeutics Market: Market Drivers and Restraints 9511.1 Market Drivers 9511.1.1 Steady Increase in the Elderly Population 9511.1.2 Stable Increase in Incidence Rates for Dermatology Diseases 9611.1.3 Increase in Awareness Levels of Disease Progression and Etiology 9611.2 Market Restraints 9611.2.1 Entry of Generics Pose a Serious Problem for Primary Manufacturers 9611.2.2 Presence of Serious Side Effects for Certain Classes of Therapeutic drugs 9612 Global Dermatology Therapeutics Market : Key Market Trends 9713 Global Dermatology Therapeutics Market: Competitive Landscape 9813.1 Overview 9813.2 Market Share Analysis 9813.3 Competitive Profiling 9813.3.1 GlaxoSmithKline plc (GSK) 9813.3.2 Johnson & Johnson 10013.3.3 Bayer AG 10213.3.4 Merck & Co., Inc 10313.3.5 Novartis AG 10513.3.6 Sanofi-Aventis 10613.3.7 LEO Pharma A/S 10713.3.8 F. Hoffmann-La Roche Ltd 10813.3.9 LOreal 10913.3.10 Galderma S.A. 10913.3.11 Nestle S.A. 11014 Dermatology Thereapeutics Market: Pipeline Analysis 11214.1 Pipeline I 11314.2 Pipeline II 11814.3 Pipeline III 13314.4 Promising Drugs under Clinical Development 14314.4.1 Voclosporin (LX211, LUVENIQ, ISA-247) 14314.4.2 ABT-874 (J-695, Briakinumab) 14314.4.3 CF-101 14414.4.4 Orencia (abatacept, CTLA4-Ig, BMS-188667) 14414.4.5 Cimzia (CDP870 certolizumab pegol) 14414.4.6 Apremilast (CC10004, ACR20) 14414.4.7 INCB18424 14414.4.8 PH-10 14414.4.9 Hivenyl 144The Future of Dermatology Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Prescription Rate to Drive Revenues Page 4/11
  • 5. Find Industry reports, Company profilesReportLinker and Market Statistics14.4.10 TF002 14515 Global Dermatology Therapeutics Market: M&A Landscape 14615.1 Mergers and Acquisitions 14615.1.1 Overview 14615.2 Licensing Agreements 14615.2.1 Overview 14615.2.2 Drug Discovery & Preclinical 14915.2.3 Phase I 15015.2.4 Phase II 15215.2.5 Phase III 15315.2.6 Approved Stage 15416 Global Dermatology Therapeutics Market : Appendix 15916.1 Market Definitions 15916.2 Abbreviations 15916.3 Research Methodology 16016.3.1 Coverage 16016.3.2 Secondary Research 16116.3.3 Primary Research 16116.3.4 Forecasts 16216.3.5 Expert Panel Validation 16416.4 Contact Us 16516.5 Disclaimer 1651.1 List of TablesTable 1: Dermatology Therapeutics Market, Global, Revenue Forecasts ($m), 2001-2009 13Table 2: Dermatology Therapeutics Market, Global, Revenue Forecasts ($m), 2009-2016 13Table 3: Dermatology Therapeutics Market, Global, Diseased Population, 2001-2009 14Table 4: Dermatology Therapeutics Market, Global, Diseased Population, 2009-2016 14Table 5: Dermatology Therapeutics Market, Global, Treatment Seeking Population, 2001-2009 15Table 6: Dermatology Therapeutics Market, Global, Treatment Seeking Population, 2009-2016 15Table 7: Dermatology Therapeutics Market, Global, Diagnosis Population, 2001-2009 16Table 8: Dermatology Therapeutics Market, Global, Diagnosis Population, 2009-2016 16Table 9: Dermatology Therapeutics Market, Global, Prescription Population, 2001-2009 17Table 10: Dermatology Therapeutics Market, Global, Prescription Population, 2009-2016 17Table 11: Dermatology Therapeutics Market, Global, Usage Patterns, 2001-2009 18Table 12: Dermatology Therapeutics Market, Global, Usage Patterns, 2009-2016 19Table 13: Dermatology Therapeutics Market, The US, Revenue Forecasts ($m), 2001-2009 20Table 14: Dermatology Therapeutics Market, The US, Revenue Forecasts ($m), 2009-2016 20Table 15: Dermatology Therapeutics Market, The U.S, Diseased Population, 2001-2009 21Table 16: Dermatology Therapeutics Market, The U.S, Diseased Population, 2009-2016 21Table 17: Dermatology Therapeutics Market, The US, Treatment Seeking Population, 2001-2009 22Table 18: Dermatology Therapeutics Market, The US, Treatment Seeking Population, 2009-2016 22Table 19: Dermatology Therapeutics Market, The US, Diagnosis Population, 2001-2009 23Table 20: Dermatology Therapeutics Market, The US, Diagnosis Population, 2009-2016 23Table 21: Dermatology Therapeutics Market, The US, Prescription Population, 2001-2009 24Table 22: Dermatology Therapeutics Market, The US, Prescription Population, 2009-2016 24Table 23: Dermatology Therapeutics Market, The US, Usage Patterns, 2001-2009 25Table 24: Dermatology Therapeutics Market, The US, Usage Patterns, 2009-2016 26Table 25: Dermatology Therapeutics Market, Europe, Revenue Forecasts ($m), 2001-2009 27Table 26: Dermatology Therapeutics Market, Europe, Revenue Forecasts ($m), 2009-2016 27Table 27: Dermatology Therapeutics Market, Europe, Diseased Population, 2001-2009 28The Future of Dermatology Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Prescription Rate to Drive Revenues Page 5/11
  • 6. Find Industry reports, Company profilesReportLinker and Market StatisticsTable 28: Dermatology Therapeutics Market, Europe, Diseased Population, 2009-2016 28Table 29: Dermatology Therapeutics Market, Europe, Treatment Seeking Population, 2001-2009 29Table 30: Dermatology Therapeutics Market, Europe, Treatment Seeking Population, 2009-2016 29Table 31: Dermatology Therapeutics Market, Europe, Diagnosis Population, 2001-2009 30Table 32: Dermatology Therapeutics Market, Europe, Diagnosis Population, 2009-2016 30Table 33: Dermatology Therapeutics Market, Europe, Prescription Population, 2001-2009 31Table 34: Dermatology Therapeutics Market, Europe, Prescription Population, 2009-2016 31Table 35: Dermatology Therapeutics Market, Europe, Usage Patterns, 2001-2009 32Table 36: Dermatology Therapeutics Market, Europe, Usage Patterns, 2009-2016 33Table 37: Dermatology Therapeutics Market, Japan, Revenue Forecasts ($m), 2001-2009 34Table 38: Dermatology Therapeutics Market, Japan, Revenue Forecasts ($m), 2009-2016 34Table 39: Dermatology Therapeutics Market, Japan, Diseased Population, 2001-2009 35Table 40: Dermatology Therapeutics Market, Japan, Diseased Population, 2009-2016 35Table 41: Dermatology Therapeutics Market, Japan, Treatment Seeking Population, 2001-2009 36Table 42: Dermatology Therapeutics Market, Japan, Treatment Seeking Population, 2009-2016 36Table 43: Dermatology Therapeutics Market, Japan, Diagnosis Population, 2001-2009 37Table 44: Dermatology Therapeutics Market, Japan, Diagnosis Population, 2009-2016 37Table 45: Dermatology Therapeutics Market, Japan, Prescription Population, 2001-2009 38Table 46: Dermatology Therapeutics Market, Japan, Prescription Population, 2009-2016 38Table 47: Dermatology Therapeutics Market, Japan, Usage Patterns, 2001-2009 39Table 48: Dermatology Therapeutics Market, Japan, Usage Patterns, 2009-2016 40Table 49: Psoriasis Therapeutics Market, Global, Revenue Forecasts ($m), 2001-2009 42Table 50: Psoriasis Therapeutics Market, Global, Revenue Forecasts ($m), 2009-2016 42Table 51: Psoriasis Therapeutics Market, Global, Average Cost of Therapy ($), 2001-2009 43Table 52: Psoriasis Therapeutics Market, Global, Average Cost of Therapy ($) 2009-2016 43Table 53: Psoriasis Therapeutics Market, Global, Diseased Population, 2001-2009 44Table 54: Psoriasis Therapeutics Market, Global, Diseased Population, 2009-2016 45Table 55: Psoriasis Therapeutics Market, Global, Treatment Seeking Population, 2001-2009 45Table 56: Psoriasis Therapeutics Market, Global, Treatment Seeking Population, 2009-2016 46Table 57: Psoriasis Therapeutics Market, Global, Diagnosis Population, 2001-2009 47Table 58: Psoriasis Therapeutics Market, Global, Diagnosis Population, 2009-2016 47Table 59: Psoriasis Therapeutics Market, Global, Prescription Population, 2001-2009 48Table 60: Psoriasis Therapeutics Market, Global, Prescription Population, 2009-2016 48Table 61: Psoriasis Therapeutics Market, Global, Usage Patterns, 2001-2009 49Table 62: Psoriasis Therapeutics Market, Global, Usage Patterns, 2009-2016 49Table 63: Psoriasis Therapeutics Phase III Clinical Pipeline, 2009 53Table 64: Psoriasis Therapeutics Phase II Clinical Pipeline, 2009 54Table 65: Atopic Dermatitis Therapeutics Market, Global, Revenue Forecasts ($m), 2001-2009 58Table 66: Atopic Dermatitis Therapeutics Market, Global, Revenue Forecasts ($m), 2009-2016 58Table 67: Atopic Dermatitis Therapeutics Market, Global, Average Cost of Therapy, 2001-2009 59Table 68: Atopic Dermatitis Therapeutics Market, Global, Average Cost of Therapy, 2009-2016 59Table 69: Atopic Dermatitis Therapeutics Market, Global, Diseased Population, 2001-2009 60Table 70: Atopic Dermatitis Therapeutics Market, Global, Diseased Population, 2009-2016 60Table 71: Atopic Dermatitis Therapeutics Market, Global, Treatment Seeking Population, 2001-2009 61Table 72: Atopic Dermatitis Therapeutics Market, Global, Treatment Seeking Population, 2009-2016 61Table 73: Atopic Dermatitis Therapeutics Market, Global, Diagnosis Population, 2001-2009 62Table 74: Atopic Dermatitis Therapeutics Market, Global, Diagnosis Population, 2009-2016 62Table 75: Atopic Dermatitis Therapeutics Market, Global, Prescription Population, 2001-2009 63Table 76: Atopic Dermatitis Therapeutics Market, Global, Prescription Population, 2009-2016 63Table 77: Atopic Dermatitis Therapeutics Market, Global, Usage Patterns, 2001-2009 64The Future of Dermatology Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Prescription Rate to Drive Revenues Page 6/11
  • 7. Find Industry reports, Company profilesReportLinker and Market StatisticsTable 78: Atopic Dermatitis Therapeutics Market, Global, Usage Patterns, 2009-2016 65Table 79: Atopic Dermatitis Therapeutics Phase III Clinical Pipeline, 2010 67Table 80: Atopic Dermatitis Therapeutics Phase II Clinical Pipeline, 2010 68Table 81: Atopic Dermatitis Therapeutics Phase I Clinical Pipeline, 2010 69Table 82: Atopic Dermatitis Therapeutics Pre-Clinical Pipeline, 2010 69Table 83: Atopic Dermatitis Therapeutics Discovery Pipeline, 2010 70Table 84: Acne Therapeutics Market, Global, Revenue Forecasts ($m), 2001-2009 72Table 85: Acne Therapeutics Market, Global, Revenue Forecasts ($m), 2009-2016 72Table 86: Acne Therapeutics Market, Global, Diseased Population, 2001-2009 73Table 87: Acne Therapeutics Market, Global, Diseased Population, 2009-2016 73Table 88: Acne Therapeutics Market, Global, Treatment Seeking Population, 2001-2009 74Table 89: Acne Therapeutics Market, Global, Treatment Seeking Population, 2009-2016 74Table 90: Acne Therapeutics Market, Global, Diagnosis Population, 2001-2009 75Table 91: Acne Therapeutics Market, Global, Diagnosis Population, 2009-2016 75Table 92: Acne Therapeutics Market, Global, Prescription Population, 2001-2009 76Table 93: Acne Therapeutics Market, Global, Prescription Population, 2009-2016 76Table 94: Acne Therapeutics Market, Global, Usage Patterns, 2001-2009 77Table 95: Acne Therapeutics Market, Global, Usage Patterns, 2009-2016 78Table 96: Acne Therapeutics Market , Clinical Pipeline , 2009 79Table 97: Rosacea Therapeutics Market, Global, Revenue Forecasts ($m), 2001-2009 84Table 98: Rosacea Therapeutics Market, Global, Revenue Forecasts ($m), 2009-2016 85Table 99: Rosacea Therapeutics Market, Global, Average Cost of Therapy, ($) 2001-2009 85Table 100: Rosacea Therapeutics Market, Global, Average Cost of Therapy ($), 2009-2016 85Table 101: Rosacea Therapeutics Market, Global, Diseased Population, 2001-2009 87Table 102: Rosacea Therapeutics Market, Global, Diseased Population, 2009-2016 87Table 103: Rosacea Therapeutics Market, Global, Treatment Seeking Population, 2001-2009 88Table 104: Rosacea Therapeutics Market, Global, Treatment Seeking Population, 2009-2016 88Table 105: Rosacea Therapeutics Market, Global, Diagnosis Population, 2001-2009 89Table 106: Rosacea Therapeutics Market, Global, Diagnosis Population, 2009-2016 89Table 107: Rosacea Therapeutics Market, Global, Prescription Population, 2001-2009 90Table 108: Rosacea Therapeutics Market, Global, Prescription Population, 2009-2016 90Table 109: Rosacea Therapeutics Market, Global, Usage Patterns, 2001-2009 91Table 110: Rosacea Therapeutics Market, Global, Usage Patterns, 2009-2016 91Table 111: Rosacea Therapeutics Clinical Pipeline, 2009 93Table 112: Dermatology Therapeutics Market, Global, Market Drivers, 2008 95Table 113: Dermatology Therapeutics Market, Global, Market Restraints, 2008 96Table 114: Dermatology Therapeutics Market, Global, Phase I Pipeline, 2009 113Table 115: Dermatology Therapeutics Market, Global, Phase II Pipeline, 2009 118Table 116: Dermatology Therapeutics Market, Global, Phase III Pipeline, 2009 133Table 117: Dermatology Therapeutics Market, Global, Licensing Agreements for Drugs in the Discovery and Preclinical Stages,2002-2009 149Table 118: Dermatology Therapeutics Market, Global, Licensing Agreements for Drugs in the Phase I Stage, 1998-2009 150Table 119: Dermatology Therapeutics Market, Global, Licensing Agreements for Drugs in the Phase II Stages, 1998-2008 152Table 120: Dermatology Therapeutics Market, Global, Licensing Agreements for Drugs in the Phase III Stages, 2002-2008 153Table 121: Dermatology Therapeutics Market, Global, Licensing Agreements for Drugs in the Approved Stages, 2001-2009 1541.2 List of FiguresFigure 1: Dermatology Therapeutics Market, Global, Revenue Forecasts ($m), 2001-2016 13Figure 2: Dermatology Therapeutics Market, Global, Diseased Population, 2001-2016 14Figure 3: Dermatology Therapeutics Market, Global, Treatment Seeking Population, 2001-2016 15Figure 4: Dermatology Therapeutics Market, Global, Diagnosis Population, 2001-2016 16The Future of Dermatology Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Prescription Rate to Drive Revenues Page 7/11
  • 8. Find Industry reports, Company profilesReportLinker and Market StatisticsFigure 5: Dermatology Therapeutics Market, Global, Prescription Population, 2001-2016 17Figure 6: Dermatology Therapeutics Market, Global, Usage Patterns, 2001-2016 18Figure 7: Dermatology Therapeutics Market, Global, Geographical Distribution of Revenues ($m), 2001-2016 19Figure 8: Dermatology Therapeutics Market, The US, Revenue Forecasts ($m), 2001-2016 20Figure 9: Dermatology Therapeutics Market, The US, Diseased Population, 2001-2016 21Figure 10: Dermatology Therapeutics Market, The U.S, Treatment Seeking Population, 2001-2016 22Figure 11: Dermatology Therapeutics Market, The US, Diagnosis Population, 2001-2016 23Figure 12: Dermatology Therapeutics Market, The US, Prescription Population, 2001-2016 24Figure 13: Dermatology Therapeutics Market, The US, Usage Patterns, 2001-2016 25Figure 14: Dermatology Therapeutics Market, Europe, Revenue Forecasts ($m), 2001-2016 27Figure 15: Dermatology Therapeutics Market, Europe, Diseased Population, 2001-2016 28Figure 16: Dermatology Therapeutics Market, Europe, Treatment Seeking Population, 2001-2016 29Figure 17: Dermatology Therapeutics Market, Europe, Diagnosis Population, 2001-2016 30Figure 18: Dermatology Therapeutics Market, Europe, Prescription Population, 2001-2016 31Figure 19: Dermatology Therapeutics Market, Europe, Usage Patterns, 2001-2016 32Figure 20: Dermatology Therapeutics Market, Japan, Revenue Forecasts ($m), 2001-2016 34Figure 21: Dermatology Therapeutics Market, Japan, Diseased Population, 2001-2016 35Figure 22: Dermatology Therapeutics Market, Japan, Treatment Seeking Population, 2001-2016 36Figure 23: Dermatology Therapeutics Market, Japan, Diagnosis Population, 2001-2016 37Figure 24: Dermatology Therapeutics Market, Japan, Prescription Population, 2001-2016 38Figure 25: Dermatology Therapeutics Market, Japan, Usage Patterns, 2001-2016 39Figure 26: Psoriasis Therapeutics Market, Global, Revenue Forecasts ($m), 2001-2016 42Figure 27: Psoriasis Therapeutics Market, Global, Average Cost of Therapy ($), 2001-2016 43Figure 28: Psoriasis Therapeutics Market, Global, Diseased Population, 2001-2016 44Figure 29: Psoriasis Therapeutics Market, Global, Treatment Seeking Population, 2001-2016 45Figure 30: Psoriasis Therapeutics Market, Global, Diagnosis Population, 2001-2016 46Figure 31: Psoriasis Therapeutics Market, Global, Prescription Population, 2001-2016 47Figure 32: Psoriasis Therapeutics Market, Global, Usage Patterns, 2001-2016 49Figure 33: Atopic Dermatitis Therapeutics Market, Global, Revenue Forecasts ($m), 2001-2016 57Figure 34: Atopic Dermatitis Therapeutics Market, Global, Average Cost of Therapy, 2001-2016 59Figure 35: Atopic Dermatitis Therapeutics Market, Global, Diseased Population, 2001-2016 60Figure 36: Atopic Dermatitis Therapeutics Market, Global, Treatment Seeking Population, 2001-2016 61Figure 37: Atopic Dermatitis Therapeutics Market, Global, Diagnosis Population, 2001-2016 62Figure 38: Atopic Dermatitis Therapeutics Market, Global, Prescription Population, 2001-2016 63Figure 39: Atopic Dermatitis Therapeutics Market, Global, Usage Patterns, 2001-2016 64Figure 40: Acne Therapeutics Market, Global, Revenue Forecasts ($m), 2001-2016 71Figure 41: Acne Therapeutics Market, Global, Diseased Population, 2001-2016 73Figure 42: Acne Therapeutics Market, Global, Treatment Seeking Population, 2001-2016 74Figure 43: Acne Therapeutics Market, Global, Diagnosis Population, 2001-2016 75Figure 44: Acne Therapeutics Market, Global, Prescription Population, 2001-2016 76Figure 45: Acne Therapeutics Market, Global, Usage Patterns, 2001-2016 77Figure 46: Acne Therapeutics Market, Clinical Pipeline by Phase, 2009 78Figure 47: Rosacea Therapeutics Market, Global, Revenue Forecasts ($m), 2001-2016 84Figure 48: Rosacea Therapeutics Market, Global, Average Cost of Therapy ($), 2001-2016 85Figure 49: Rosacea Therapeutics Market, Global, Diseased Population, 2001-2016 86Figure 50: Rosacea Therapeutics Market, Global, Treatment Seeking Population, 2001-2016 87Figure 51: Rosacea Therapeutics Market, Global, Diagnosis Population, 2001-2016 88Figure 52: Rosacea Therapeutics Market, Global, Prescription Population, 2001-2016 89Figure 53: Rosacea Therapeutics Market, Global, Usage Patterns, 2001-2016 90Figure 54: Rosacea Therapeutics Clinical Pipeline by Drug Development Phase, 2009 92The Future of Dermatology Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Prescription Rate to Drive Revenues Page 8/11
  • 9. Find Industry reports, Company profilesReportLinker and Market StatisticsFigure 55: Dermatology Therapeutics Market, Global, Market Indicators, 2009 95Figure 56: Dermatology Therapeutics Market, Global, Key Market Events, 2008-2015 97Figure 57: Dermatology Therapeutics Market, Global, Leading Companies, 2009 98Figure 58: Dermatology Therapeutics Market, Global, Pipeline by Phase, 2009 112Figure 59: Dermatology Therapeutics Market, Global, Licensing Agreements Split by Indication, 2009 147Figure 60: Dermatology Therapeutics Market, Global, Licensing Agreements Split by Clinical Trial Phase, 2009 147Figure 61: Dermatology Therapeutics Market, Global, Licensing Agreements Split by Geography, 2009 148Figure 62: GBI Research Methodology, 2010 161Figure 63: GBI Research Market Forecasting Methodology, 2010 164Companies mentionedGlaxoSmithKline plc (GSK)Johnson & JohnsonBayer AGMerck & Co., IncNovartis AGSanofi-AventisLEO Pharma A/SF. Hoffmann-La Roche LtdLOrealGalderma S.ANestle S.A.The Future of Dermatology Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Prescription Rate to Drive Revenues Page 9/11
  • 10. Find Industry reports, Company profilesReportLinker and Market Statistics Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93 If you have any questions please visit http://www.reportlinker.com/notify/contact Order Information Please verify that the product information is correct and select the format(s) you require. The Future of Dermatology Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Prescription Rate t o Drive Revenues Product Formats Please select the product formats and the quantity you require. 1 User License--USD 3 500.00 Quantity: _____ Site License--USD 7 000.00 Quantity: _____ Corporate License--USD 10 500.00 Quantity: _____ Contact Information Please enter all the information below in BLOCK CAPITALS Title: Mr Mrs Dr Miss Ms Prof First Name: _____________________________ Last Name: __________________________________ Email Address: __________________________________________________________________________ Job Title: __________________________________________________________________________ Organization: __________________________________________________________________________ Address: __________________________________________________________________________ City: __________________________________________________________________________ Postal / Zip Code: __________________________________________________________________________ Country: __________________________________________________________________________ Phone Number: __________________________________________________________________________ Fax Number: __________________________________________________________________________The Future of Dermatology Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Prescription Rate to Drive Revenues Page 10/11
  • 11. Find Industry reports, Company profilesReportLinker and Market Statistics Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box. Payment by credit card Card Number: ______________________________________________ Expiry Date __________ / _________ CVV Number _____________________ Card Type (ex: Visa, Amex…) _________________________________ Payment by wire transfer Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189 Payment by check UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE Customer signature:   Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93The Future of Dermatology Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Prescription Rate to Drive Revenues Page 11/11